Profound Medical Corp.
Public company- Headquarters
- MISSISSAUGA
- Ticker
- PROF
- CIK
- 0001628808
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| PresidentRichard R. Fabian | Sep 3, 2026 | Appointed |
| CFOMatthew Sobczyk | Aug 17, 2026 | Appointed |
| CFORashed Dewan | Aug 17, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- Fresenius SE & Co. KGaA
Plant closure: CA
- DarioHealth Corp.
Chairman of the Board appointed: John R. Palumbo
- FRACTYL HEALTH, INC.
Class III director appointed: Michael Wartell
- FEMASYS INC
director departs: Kenneth D. Eichenbaum, M.D., M.S.E.
- Executive appointment
President appointed: Richard R. Fabian
Richard R. Fabian was named President of Profound Medical Corp., effective September 1, 2026. Richard R. Fabian succeeds Mathieu Burtnyk, PhD. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 3, 2026Role: President
- Executive appointment
CFO appointed: Matthew Sobczyk
Matthew Sobczyk was named Interim Chief Financial Officer of Profound Medical Corp., effective August 14, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 17, 2026Role: Interim Chief Financial Officer
- Executive departure
CFO departs: Rashed Dewan
Rashed Dewan, Chief Financial Officer of Profound Medical Corp., resigns the role, effective August 14, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 17, 2026Role: Chief Financial Officer
Last verified Nov 8, 2026